Abraham Ceesay, Director: Pacira BioSciences PCRX Sell · Filed 25/09/08

Trade details

Type: Insider sale
Amount: $64,005.26
Shares · price: 2,354 sh · $27.19 a share
Held after: 9,039 sh
Stock: Pacira BioSciences PCRX
Person: Abraham CeesayDirector
Trade date: 25/09/04
Filed: 25/09/08
Days to filing: 4 days

Sold 20.7% of holdings

Share of holding sold: 20.7%

Pacira BioSciences trades, last 26 weeks

What else happened in Pacira BioSciences around then

Filed or reported within 30 days of the trade day · 25/08/05~25/10/04

Abraham Ceesay's recent trades

Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$76.2K
1,952 sh
$76.2K
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$8,570
215 sh
$8,570
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$1,765
43 sh
$1,765
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$4M
99,480 sh
$4M
Filed 06/29
Traded 06/29
Abraham CeesayDirector
Planned salePacira BioSciences
Planned sale
Pacira BioSciences
PCRX
$210.4K
9,039 sh
$210.4K
Filed 06/12
Traded 06/12